Gumaod, Arlene .
HRN: 23-64-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2023
CEFUROXIME 1.5GM (VIAL)
08/29/2023
08/31/2023
IV
1.5
Q8
Sp LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes